Claus et al. studied 369 women (mean age 53.8 years) with pure DCIS selected from a case-control study of carcinoma in situ and found that 2.4% had pathogenic variants in BRCA2 and 0.8% in BRCA1 [12]. The gene discussed is BRCA2; the disease is ductal breast carcinoma in situ.